Home » EPIC Archives: AVCT

AVCT News Archives

preCISION and Affimer based cancer therapies

Avacta Group Plc

In this interview, Alastair Smith discusses our development of a rapid antigen test for SARS-Cov-2 and the progress of our preCISIONTM and Affimer® based cancer therapies. Watch below.  Source: IG TV Avacta Group Plc ...

Read Article »

Avacta Group wins Small Cap award

Avacta Group Plc

Avacta Group has won Technology Company of the Year at the Small Cap 2020 Awards. Over 200 attendees, all supporters of the small cap community congregated online at the (optional) ...

Read Article »

How diagnostic test performance is measured

Avacta Group Plc

In this video, Avacta’s Chief Executive Officer Alastair Smith explains how diagnostic test performance is measured. Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic ...

Read Article »

The Quest for a Cure

Avacta Group Plc

In 2003, the outbreak of severe acute respiratory syndrome (SARS) became the first pandemic of the 21st century and exemplified the rapid rate at which a virus can spread internationally. ...

Read Article »